The model B6dom1 minor histocompatibility antigen is encoded by a mouse homolog of the yeast STT3 gene

Immunogenetics

Volumn 54, Issue 8, 2002, Pages 562-569

  McBride, Kevin ^a   Baron, Chantal ^c   Picard, Serge ^a   Martin, Stéphanie ^a   Boismenu, Daniel ^b   Bell, Alex ^b   Bergeron, John ^b   Perreault, Claude ^c  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^b M N P Proteomics/Struct Genom   (Canada)

^c MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

Antigen presentation; Antigens peptides epitopes; Comparative immunology; Cytotoxic T lymphocyte

Indexed keywords

AMINO ACID; MINOR HISTOCOMPATIBILITY ANTIGEN; PROTEIN;

ALLELE; AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CANCER IMMUNOTHERAPY; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXIC T LYMPHOCYTE; DNA SEQUENCE; GENETIC ANALYSIS; GENETIC CODE; GENETIC RESISTANCE; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOSITY; MOLECULAR CLONING; MOUSE STRAIN; NONHUMAN; ORTHOLOGY; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROTEIN FAMILY; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; TARGET CELL; YEAST;

AMINO ACID SEQUENCE; ANIMALS; CELLS, CULTURED; COMPUTATIONAL BIOLOGY; CYTOTOXICITY TESTS, IMMUNOLOGIC; GENES, FUNGAL; GLYCOSYLTRANSFERASES; HUMANS; IMMUNODOMINANT EPITOPES; MASS SPECTROMETRY; MEMBRANE PROTEINS; MICE; MINOR HISTOCOMPATIBILITY ANTIGENS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; SACCHAROMYCES CEREVISIAE PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; T-LYMPHOCYTES, CYTOTOXIC; YEASTS;

ANIMALIA;

EID: 18744376856     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00251-002-0502-4     Document Type: Article

References (43)

1. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215:403-410
2. Beekman NJ, van Veelen PA, van Hall T, Neisig A, Sijts A, Camps M, Kloetzel PM, Neefjes JJ, Melief CJ, Ossendorp F (2000) Abrogation of CTL epitope processing by single amino acid substitution flanking the C-terminal proteasome cleavage site. J Immunol 164:1898-1905
3. Brickner AG, Warren EH, Caldwell JA, Akatsuka Y, Golovina TN, Zarling AL, Shabanowitz J, Eisenlohr LC, Hunt DF, Engelhard VH, Riddell SR (2001) The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing. J Exp Med 193:195-205
4. Chen W, Anton LC, Bennink JR, Yewdell JW (2000) Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. Immunity 12:83-93
5. Choi EY, Yoshimura Y, Christianson GJ, Sproule TJ, Malarkannan S, Shastri N, Joyce S, Roopenian DC (2001) Quantitative analysis of the immune response to mouse non-MHC transplantation antigens in vivo: The H60 histocompatibility antigen dominates over all others. J Immunol 166:4370-4379
6. Deane CM, Allen FH, Taylor R, Blundell TL (1999) Carbonyl-carbonyl interactions stabilize the partially allowed Ramachandran conformations of asparagine and aspartic acid. Protein Eng 12:1025-1028
7. Degano M, Garcia KC, Apostolopoulos V, Rudolph MG, Teyton L, Wilson IA (2000) A functional hot spot for antigen recognition in a superagonist TCR/MHC complex. Immunity 12:251-261
8. Den Haan JM, Sherman NE, Blokland E, Huczko E, Koning F, Drijfhout JW, Skipper J, Shabanowitz J, Hunt DF, Engelhard VH, Goulmy E (1995) Identification of a graft versus host disease-associated human minor histocompatibility antigen. Science 268:1476-1480
9. Deng Y, Yewdell JW, Eisenlohr LC, Bennink JR (1997) MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL. J Immunol 158:1507-1515
10. dom1) encoded by the classical H7 minor histocompatibility locus. J Immunol 162:4502-4510
11. Fischer-Lindahl K (1991) Minor histocompatibility antigens. Trends Genet 7:219-24
12. Fontaine P, Roy-Proulx G, Knafo L, Baron C, Roy DC, Perreault C (2001) Adoptive transfer of T lymphocytes targeted to a single immunodominant minor histocompatibility antigen eradicates leukemia cells without causing graft-versus-host disease. Nat Med 7:789-794
13. Helenius A, Aebi M (2001) Intracellular functions of N-linked glycans. Science 291:2364-2369
14. Jonson PH, Petersen SB (2001) A critical view on conservative mutations. Protein Eng 14:397-402
15. Kedl RM, Rees WA, Hildeman DA, Schaefer B, Mitchell T, Kappler J, Marrack P (2000) T cells compete for access to antigen-bearing antigen-presenting cells. J Exp Med 192:1105-1114
16. Loveland B, Simpson E (1986) The non-MHC transplantation antigens: Neither weak nor minor. Immunol Today 7:223-229
17. Loyer V, Fontaine P, Pion S, Hétu F, Roy DC, Perreault C (1999) The in vivo fate of APCs displaying minor H antigens and/or MHC differences is regulated by CTLs specific for immunodominant class I-associated epitopes. J Immunol 163:6462-6467
18. Malarkannan S, Shih PP, Eden PA, Horng, Zuberi AR, Christianson G, Roopenian D, Shastri N (1998) The molecular and functional characterization of a dominant minor H antigen, H60. J Immunol 161:3501-3509
19. Malarkannan S, Horng T, Eden P, Gonzalez F, Shih P, Brouwenstijn N, Klinge H, Christianson G, Roopenian D, Shastri N (2000) Differences that matter: Major cytotoxic T cell-stimulating minor histocompatibility antigens. Immunity 13:333-344
20. Mendoza LM, Paz P, Zuberi A, Christianson G, Roopenian D, Shastri N (1997) Minors held by majors: The H13 minor histocompatibility locus defined as a peptide-MHC class I complex. Immunity 7:461-472
21. Mendoza LM, Villaflor G, Eden P, Roopenian D, Shastri N (2001) Distinguishing self from nonself: Immunogenicity of the murine H47 locus is determined by a single amino acid substitution in an unusual peptide. J Immunol 166:4438-4445
22. Morse MC, Bleau G, Dabhi VM, Hétu F, Drobetsky EA, Lindahl KF, Perreault C (1996) The COI mitochondrial gene encodes a minor histocompatibility antigen presented by H2-M3. J Immunol 156:3301-3307
23. Ostrov DA, Roden MM, Shi W, Palmieri E, Christianson GJ, Mendoza L, Villaflor G, Tilley D, Shastri N, Grey H, Almo SC, Roopenian D, Nathenson SG (2002) How H13 histocompatibility peptides differing by a single methyl group and lacking conventional MHC binding anchor motifs determine self-nonself discrimination. J Immunol 168:283-289
24. Parker KC, Bednarek MA, Coligan JE (1994) Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 152: 163-175
25. Perreault C, Décary F, Brochu S, Gyger M, Bélanger R, Roy D (1990) Minor histocompatibility antigens. Blood 76:1269-1280
26. Perreault C, Jutras J, Roy DC, Filep JG, Brochu S (1996) Identification of an immunodominant mouse minor histocompatibility antigen (MiHA). T cell response to a single dominant MiHA causes graft-versus-host disease. J Clin Invest 98:622-628
27. Perreault C, Roy DC, Fortin C (1998) Immunodominant minor histocompatibility antigens: The major ones. Immunol Today 19:69-74
28. Pion S, Fontaine P, Desaulniers M, Jutras J, Filep JG, Perreault C (1997) On the mechanisms of immunodominance in cytotoxic T lymphocyte responses to minor histocompatibility antigens. Eur J Immunol 27:421-430
29. Pion S, Christianson GJ, Fontaine P, Roopenian DC, Perreault C (1999) Shaping the repertoire of cytotoxic T-lymphocyte responses: Explanation for the immunodominance effect whereby cytotoxic T lymphocytes specific for immunodominant antigens prevent recognition of nondominant antigens. Blood 93:952-962
30. Rammensee HG, Friede T, Stevanovic S (1995) MHC ligands and peptide motifs: First listing. Immunogenetics 41:178-228
31. Roopenian DC, Christianson GJ, Davis AP, Zuberi AR, Mobraaten LE (1993) The genetic origin of minor histocompatibility antigens. Immunogenetics 38:131-140
32. Roy-Proulx G, Meunier MC, Lanteigne AM, Brochu S, Perreault C (2001) Immunodomination results from functional differences between competing CTL. Eur J Immunol 31:2284-2292
33. Schirle M, Keilholz W, Weber B, Gouttefangeas C, Dumrese T, Becker HD, Stevanovic S, Rammensee HG (2000) Identification of tumor-associated MHC class I ligands by a novel T cell-independent approach. Eur J Immunol 30:2216-2225
34. Scott DM, Ehrmann IE, Ellis PS, Bishop CE, Agulnik AI, Simpson E, Mitchell MJ (1995) Identification of a mouse male-specific transplantation antigen, H-Y. Nature 376:695-698
35. Simpson E, Roopenian D (1997) Minor histocompatibility antigens. Curr Opin Immunol 9:655-661
36. Spirig U, Glavas M, Bodmer D, Reiss G, Burda P, Lippuner V, te Heesen S, Aebi M (1997) The STT3 protein is a component of the yeast oligosaccharyltransferase complex. Mol Gen Genet 256:628-637
37. Wang W, Meadows LR, den Haan JM, Sherman NE, Chen Y, Blokland E, Shabanowitz J, Agulnik AI, Hendrickson RC, Bishop CE, Hunt DF, Goulmy E, Engelhard VH (1995) Human H-Y: A male-specific histocompatibility antigen derived from the SMCY protein. Science 269:1588-1590
38. Yeager M, Carrington M, Hughes AL (2000) Class I and class II MHC bind self peptide sets that are strikingly different in their evolutionary characteristics. Immunogenetics 51:8-15
39. Yewdell JW, Bennink JR (1999) Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu Rev Immunol 17:51-88
40. Yoshida S, Ohya Y, Nakano A, Anraku Y (1995) STT3, a novel essential gene related to the PKC1/STT1 protein kinase pathway, is involved in protein glycosylation in yeast. Gene 164:167-172
41. Yoshida S, Matsuura A, Merregaert J, Anraku Y (1999) Schizosaccharomyces pombe stt3+ is a functional homologue of Saccharomyces cerevisiae STT3 which regulates oligosaccharyltransferase activity. Yeast 15:497-505
42. Zuberi AR, Christianson GJ, Mendoza LM, Shastri N, Roopenian DC (1998) Positional cloning and molecular characterization of an immunodominant cytotoxic determinant of the mouse H3 minor histocompatibility complex. Immunity 9:687-698
43. Zufferey R, Knauer R, Burda P, Stagljar I, te Heesen S, Lehle L, Aebi M (1995) STT3, a highly conserved protein required for yeast oligosaccharyl transferase activity in vivo. EMBO J 14:4949-4960